Skip to Main Content

Paper Details

Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.
Sci Transl Med
46
2017
Author NameAffiliation
S??ren BuusUniversity of Copenhagen
  • 1 - 1

Datasets

Release 1.2